Target intelligence / Profile preview

Fusarium mycotoxins (Fusariotoxins)

Molecular classification
Mycotoxin, Fungal secondary metabolite
01

Overview

Fusarium mycotoxins, commonly known as fusariotoxins, are a diverse group of secondary metabolites produced by fungi of the genus Fusarium, which frequently contaminate agricultural crops such as wheat, maize, and barley (Source: WHO, 2018). This group includes several chemically distinct classes, most notably trichothecenes (e.g., deoxynivalenol and T-2 toxin), zearalenone, and fumonisins, each possessing unique toxicological profiles (Source: EFSA, 2017). These compounds are not therapeutic targets but are potent environmental toxicants that disrupt essential cellular functions. Trichothecenes exert toxicity by binding to the 60S ribosomal subunit and inhibiting protein synthesis, while zearalenone acts as a competitive agonist for estrogen receptors, and fumonisins inhibit the enzyme ceramide synthase (Source: PubMed, PMID: 21839735; NIH, 2020). Exposure to these toxins is linked to a variety of human and animal health issues, including acute gastrointestinal distress, esophageal cancer, and reproductive disorders. Because they are xenobiotics rather than drug targets, pharmacological management is generally limited to the use of sequestering agents like activated charcoal or specialized clay minerals to prevent intestinal absorption (Source: Journal of Animal Science and Biotechnology, 2013). Research in this field primarily focuses on agricultural mitigation and food safety monitoring rather than drug development.

Other names
FusariotoxinsFusarium toxinsTrichothecenesZearalenoneFumonisinsDeoxynivalenolT-2 toxin
02

Mechanism of action

Therapeutic intervention primarily involves the use of non-specific adsorbent agents that physically bind the toxins within the gastrointestinal tract, thereby preventing their systemic absorption and reducing bioavailability.

03

Biological functions

Inhibition of protein synthesisEstrogen receptor agonismInhibition of ceramide synthaseInduction of ribotoxic stressDisruption of sphingolipid metabolism
04

Disease associations

MycotoxicosisAlimentary toxic aleukiaEsophageal cancerHyperestrogenismImmunosuppressionNeural tube defectsLeukoencephalomalacia
05

Safety considerations

Acute gastrointestinal toxicityChronic carcinogenicityTeratogenicityReproductive dysfunctionSevere immunotoxicityFood chain contamination
06

Interacting drugs

Activated charcoal

4 more in the full profile.

07

Biomarkers

Urinary deoxynivalenol-glucuronideSerum fumonisin B1Urinary zearalenoneSphinganine/sphingosine ratio in serum

Beyond the preview

Go deeper on Fusarium mycotoxins (Fusariotoxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusarium mycotoxins (Fusariotoxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call